Surgery Partners Expands into Dialysis Market with Acquisition of Preferred Vascular Group
- Surgery Partners acquires Preferred Vascular Group, entering the $6 billion dialysis access market with significant growth potential.
- The acquisition strengthens Surgery Partners' service offerings and enhances patient care through PVG's high-quality outpatient services.
- Leadership from PVG will remain post-acquisition, ensuring operational continuity and leveraging Surgery Partners' resources for market impact.
Surgery Partners Expands Focus on Dialysis Care with Strategic Acquisition
Surgery Partners (NASDAQ: SGRY), a key operator within the surgical facility industry, is set to enhance its position in the vascular services market following the recent acquisition of Preferred Vascular Group (PVG). This acquisition, advised by Ziegler, a notable specialty investment bank, allows Surgery Partners entry into the lucrative $6 billion dialysis access market. This sector, which sees over two million procedures performed annually, represents a significant growth opportunity for the company. PVG, established in 2005 and currently operating eight Ambulatory Surgical Centers (ASCs) in Georgia and Ohio, specializes in dialysis access procedures, which are vital for patients requiring these essential treatments.
PVG’s model exemplifies a commitment to high-quality outpatient services, underscored by the operational support of 16 dedicated physicians and a workforce of over 160 employees. By integrating PVG into its portfolio, Surgery Partners not only strengthens its service offerings but also demonstrates a strategic alignment with advancing patient care. The leadership from PVG will remain intact post-acquisition, ensuring continuity in operations and a focused approach on leveraging Surgery Partners’ resources to amplify their market impact. The collaboration aims to enhance clinical outcomes and expand the breadth of vascular services available to patients.
The strategic importance of this acquisition is underscored by insights from Andrew Colbert, Senior Managing Director at Ziegler, who highlights the scalability potential it unlocks for PVG in the national arena. The cooperative effort between Ziegler and PVG has been pivotal in navigating the complexities of the transaction, a sentiment echoed by PVG CEO Dustin Greene, who noted Ziegler's critical advisory role throughout the process. As Surgery Partners seeks to improve patient experiences in the dialysis space, this acquisition marks a definitive step towards greater service innovation and accessibility in outpatient care.
In addition to this acquisition, Ziegler's commitment to providing comprehensive advisory services solidifies its reputation in healthcare investment banking. Their role in this transaction reflects a broader dedication to fostering strategic growth in the healthcare sector.
With continued focus on expanding its vascular service offerings and improving patient outcomes, Surgery Partners positions itself well within the evolving landscape of healthcare delivery, addressing a pressing need for effective dialysis care solutions.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

